Stockreport

First Wave BioPharma CEO to Present at the BIO CEO & Investor Conference 2024

First Wave BioPharma, Inc.  (FWBI) 
PDF BOCA RATON, Fla., Feb. 13, 2024 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ: FWBI), (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmace [Read more]